Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda - Concepedia

Concepedia

Publication | Open Access

Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda

DOI Full Paper Access

49

Citations

9

References

2016

Year

Jacqueline E. Tate, Fidèle Ngabo, Philippe Donnen, Maurice Gatera, Jeannine Uwimana, Celse Rugambwa, Jason M. Mwenda, Umesh D. Parashar

Clinical Infectious Diseases

Abstract

Rotavirus vaccine is effective in preventing rotavirus disease in Rwandan children who began their rotavirus vaccine series from 7 to 18 weeks of age. Protection from vaccination was sustained after the first year of life.

References

	Year	Citations
Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine Timo Vesikari, David O. Matson, Penelope H. Dennehy, New England Journal of Medicine	2006	1.9K
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis Guillermo M. Ruiz‐Palacios, Irene Pérez‐Schael, F. Raúl Velázquez, New England Journal of Medicine	2006	1.8K
Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants Shabir A. Madhi, Nigel A. Cunliffe, A. Duncan Steele, New England Journal of Medicine	2010	906
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial The Lancet VaccinationVaccine SafetySevere Rotavirus GastroenteritisPediatric EpidemiologyGlobal Health	2010	828
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial George Armah, Samba O. Sow, Robert F. Breiman, The Lancet VaccinationVaccine SafetyVaccine DevelopmentSevere Rotavirus GastroenteritisGlobal Health	2010	658
Meeting of the immunization Strategic Advisory Group of Experts, April 2008--conclusions and recommendations. PubMed	2007	216
Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 – Conclusions and recommendations 。 Who Biologicals VaccinologyVaccine SafetyVaccinationOctober 2009Vaccine Development	2010	143
Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 - conclusions and recommendations. PubMed VaccinologyVaccine SafetyImmunohematologyVaccinationOctober 2009	2009	90
Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis Fidèle Ngabo, Jacqueline E. Tate, Maurice Gatera, The Lancet Global Health	2016	80

Page 1